Evidence map›Paper›PMID 27260258›Full record

Observational studyIntensive care medicine2016

Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.

Anne-Sophie Truche, Michael Darmon, Sébastien Bailly, Christophe Clec'h, Claire Dupuis, Benoit Misset, Elie Azoulay, Carole Schwebel, Lila Bouadma, Hatem Kallel and 12 more

Erratum issuedAbstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Intensive care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 1 country.

Anne-Sophie TrucheUMR 1137, IAME Team 5, DeSCID: Decision Sciences in Infectious Diseases, Control and Care, Sorbonne Paris Cité, Inserm/Paris Diderot University, 75018, Paris, France.ORCID http://orcid.org/0000-0003-1570-2251
Michael DarmonMedical Intensive Care Unit, Saint Etienne University Hospital, Saint-Etienne, France.
Sébastien BaillyUMR 1137, IAME Team 5, DeSCID: Decision Sciences in Infectious Diseases, Control and Care, Sorbonne Paris Cité, Inserm/Paris Diderot University, 75018, Paris, France.
Christophe Clec'hUMR 1137, IAME Team 5, DeSCID: Decision Sciences in Infectious Diseases, Control and Care, Sorbonne Paris Cité, Inserm/Paris Diderot University, 75018, Paris, France.
Claire DupuisUMR 1137, IAME Team 5, DeSCID: Decision Sciences in Infectious Diseases, Control and Care, Sorbonne Paris Cité, Inserm/Paris Diderot University, 75018, Paris, France.
Benoit MissetIntensive Care Unit, Saint Joseph Hospital Network, Paris, France.
Elie AzoulayMedical Intensive Care Unit, AP-HP, Saint Louis Hospital, Paris, France.
Carole SchwebelMedical Intensive Care Unit, Grenoble University Hospital, Grenoble 1 University, U823, La Tronche, France.
Lila BouadmaAP-HP, Bichat Hospital, Medical and Infectious Diseases Intensive Care Unit, Paris Diderot University, 75018, Paris, France.
Hatem KallelMedical Surgical ICU, Centre Hospitalier de Cayenne, Guyane, France.
Christophe AdriePhysiology Department, Cochin University Hospital, Assistance Publique Des Hôpitaux de Paris (AP-HP), Paris Descartes University, Sorbonne Cite, Paris, France.
Anne-Sylvie DumenilAP-HP, Antoine Béclère University Hospital, Medical-surgical Intensive Care Unit, Clamart, France.
Laurent ArgaudMedical Intensive Care Unit, Lyon University Hospital, Lyon, France.
Guillaume MarcotteSurgical ICU, Edouard Herriot University Hospital, Lyon, France.
Samir JamaliCritical Care Medicine Unit Dourdan Hospital, Dourdan, France.
Philippe ZaouiNephrology, Grenoble University Hospital, La Tronche, France.
Virginie LaurentMedical Intensive Care Unit, André Mignot Hospital, Versailles, France.
Dany Goldgran-ToledanoIntensive Care Unit, Gonesse Hospital, Gonesse, France.
Romain SonnevilleAP-HP, Bichat Hospital, Medical and Infectious Diseases Intensive Care Unit, Paris Diderot University, 75018, Paris, France.
Bertrand SouweineMedical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France.
Jean-Francois TimsitUMR 1137, IAME Team 5, DeSCID: Decision Sciences in Infectious Diseases, Control and Care, Sorbonne Paris Cité, Inserm/Paris Diderot University, 75018, Paris, France. Jean-francois.timsit@bch.aphp.fr.
OUTCOMEREA Study Group
Inserm · FRDélégation Paris 7 · FRDélégation Paris 5 · FRCentre Hospitalier Universitaire de Grenoble · FRHospices Civils de Lyon · FRAssistance Publique – Hôpitaux de Paris · FRHôpital André Mignot · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe best renal replacement therapy (RRT) modality remains controversial. We compared mortality and short- and long-term renal recovery between patients treated with continuous RRT and intermittent hemodialysis.

methodsPatients of the prospective observational multicenter cohort database OUTCOMEREA™ were included if they underwent at least one RRT session between 2004 and 2014. Differences in patients' baseline and daily characteristics between treatment groups were taken into account by using a marginal structural Cox model, allowing one to substantially reduce the bias resulting from confounding factors in observational longitudinal data analysis. The composite primary endpoint was 30-day mortality and dialysis dependency.

resultsAmong 1360 included patients with RRT, 544 (40.0 %) and 816 (60.0 %) were initially treated by continuous RRT and intermittent hemodialysis, respectively. At day 30, 39.6 % patients were dead. Among survivors, 23.8 % still required RRT. There was no difference between groups for the primary endpoint in global population (HR 1.00, 95 % CI 0.77-1.29; p = 0.97). In patients with higher weight gain at RRT initiation, mortality and dialysis dependency were significantly lower with continuous RRT (HR 0.54, 95 % CI 0.29-0.99; p = 0.05). Conversely, this technique appeared to be deleterious in patients without shock (HR 2.24, 95 % CI 1.24-4.04; p = 0.01). Six-month mortality and persistent renal dysfunction were not influenced by the RRT modality in patients with dialysis dependence at ICU discharge.

conclusionContinuous RRT did not appear to improve 30-day and 6-month patient outcomes. It seems beneficial for patients with fluid overload, but might be deleterious in the absence of hemodynamic failure.

Indexed as

Acute Kidney InjuryAgedChi-Square DistributionFemaleHumansIntensive Care UnitsMaleMiddle AgedProportional Hazards ModelsProspective StudiesRenal DialysisRenal Replacement TherapyTreatment OutcomeAcute kidney injuryIntensive care unitMarginal structural modelRenal replacement therapy

Identifiers

PMID27260258
OpenAlexW2409331912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.